Quest Laboratories is scheduled to hit the market on May 15, 2024 and close on May 17, 2024. Quest Laboratories plans to raise around ₹43.16 Cr through an IPO with a sale of up to 4,449,600 equity shares of ₹10 each. The Retail offered 35%, QIB Shares Offered 50%, HNI Shares Offered 15%
Quest Laboratories Limited, established in June 1998, specializes in manufacturing a diverse range of pharmaceutical products, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, and antidepressants. Operating primarily in the domestic market, the company serves twelve states and two union territories, with a manufacturing facility situated in Dhar, Madhya Pradesh. Holding prestigious certifications such as WHO Schedule M GMP and GLP, ISO/IEC 17025:2017, and ISO 9001:2015, Quest Laboratories is committed to maintaining high-quality standards across its operations.
As of December 31st, 2023, Quest Laboratories employs 83 dedicated individuals responsible for various crucial aspects of its manufacturing processes. These employees oversee production, quality control, technical and engineering support services, inventory management, administration, and accounting functions. Additionally, the team manages essential tasks like storage, packing, and dispatch to ensure efficient operations and timely delivery of pharmaceutical products to customers nationwide.
Quest Laboratories IPO Details
Quest Laboratories IPO opens on May 15, 2024, and closes on May 17, 2024. The Listing date for Quest Laboratories IPO is on May 23, 2024. The price band for IPO is ₹93 to ₹97 per share and lot size of 1200 Shares.
| IPO Date | May 15, 2024 to May 17, 2024 |
| Listing Date | May 23, 2024 |
| Price | ₹93 to ₹97 per share |
| Lot Size | 1200 Shares |
| Issue Size | ₹43.16 Cr |
| Face Value | ₹10 per share |
Quest Laboratories IPO Tentative Timetable
Quest Laboratories opening date is May 15, 2024 and close date is May 17, 2024. The IPO allotment date is May 21, 2024. The refund initiation of IPO is on May 22, 2024. The credit of shares in demat account is on May 22, 2024. The listing date is on May 23, 2024.
| Event | Date |
|---|---|
| IPO Opening | May 15, 2024 |
| IPO Closing | May 17, 2024 |
| IPO Allotment Date | May 21, 2024 |
| Refund Initiation | May 22, 2024 |
| Shares Credit to Demat | May 22, 2024 |
| Lisiting Date | May 23, 2024 |
Quest Laboratories IPO Lot Size
Lot Size of this IPO is 1200 shares. A retail-individual investor can apply for up to 1 lots (1200 shares or ₹116,400).
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail(Minimum) | 1 | 1200 | ₹116,400 |
| Retail(Maximum) | 1 | 1200 | ₹116,400 |
| HNI (Minimum) | 2 | 2400 | ₹232,800 |
Quest Laboratories IPO Promoter Holding
| Pre Issue Share Holding | 90.36% |
| Post Issue Share Holding | 65.82% |
Quest Laboratories IPO Review
Quest Laboratories Ltd. is all set to launch its maiden book building route IPO, aiming to raise Rs. 43.16 crore through the issuance of 4449600 equity shares priced between Rs. 93 to Rs. 97 per share. The company, engaged in manufacturing pharmaceutical formulations, has shown impressive financial growth in recent years, especially with a significant boost in profits since FY22. However, with the issue appearing fully priced based on FY24 earnings, potential investors are advised to carefully consider their investment decisions.
Quest Laboratories Ltd., known for its wide range of pharmaceutical products meeting various medical needs, holds prestigious certifications like WHO Schedule M GMP and GLP. The company's commitment to quality is evident through its ISO certifications and state-of-the-art laboratory facilities. Financially, the company has reported consistent growth in total income and net profit over the last few fiscal years, with a notable average RoNW of 32.28%. Although the post-IPO expansion plans and utilization of proceeds seem promising, the pricing metrics indicate a fully valued issue.
While Quest Laboratories Ltd. presents a compelling investment opportunity for well-informed investors with moderate funds looking at the medium term, the fully priced nature of the IPO based on FY24 earnings may raise concerns regarding its sustainability in the future. With a competitive market landscape and fluctuating profitability margins, potential investors are advised to conduct thorough due diligence before making any investment decisions. Overall, Quest Laboratories Ltd.'s IPO showcases potential for growth but demands a cautious approach from interested investors.
Quest Laboratories IPO Subscription Status (Bidding Details)
Table not foundQuest Laboratories IPO Broker Recommendations
- Capital Market: To be updated soon
- Anand Rathi: To be updated soon
- SMC Global: To be updated soon
- Arihant Capital: To be updated soon
Quest Laboratories IPO FAQs
What is Quest Laboratories IPO?
Quest Laboratories is issuing 4,449,600 equity shares with a face value of 10 each, totaling up to ₹43.16 Cr. The shares are being offered at a price of ₹93 to ₹97 each, with a minimum order quantity of 1200 shares.
Bigshare Services Pvt Ltd is the registrar for the IPO, and the shares are planned to be listed on the BSE and NSE.
When Quest Laboratories IPO will open?
Quest Laboratories will open on May 15, 2024 for QIB, NII, and Retail Investors.
When Quest Laboratories IPO will end?
Quest Laboratories will end on May 17, 2024.
What is Quest Laboratories IPO Size?
Quest Laboratories IPO size is ₹43.16 Cr.
What is Quest Laboratories IPO Price Band?
Quest Laboratories price band is ₹93 to ₹97 per share.
What is the Quest Laboratories IPO Allotment Date?
Quest Laboratories allotment date is May 21, 2024.
What is the Quest Laboratories IPO Listing Date?
Quest Laboratories listing date is May 23, 2024. The IPO is to be listed on BSE and NSE.
How to Quest Laboratories IPO through Zerodha?
To apply for the IPO “Quest Laboratories” on Zerodha, log in to the Zerodha website or app, go to the Portfolio section, and click on IPO. Then, click on the “Apply” button and enter your UPI ID, the desired quantity, and the price. Submit the IPO application form and then approve the mandate on your UPI app. To complete the process, you should have an demat account. If you don't have one, open a demat account with Zerodha.
How to Apply Quest Laboratories IPO through Upstox?
To apply for the IPO “Quest Laboratories” on Upstox, log in to the Upstox website or app, click on IPO. Then, click on the “Apply” button and enter your UPI ID, the desired quantity, and the price. Submit the IPO application form and then approve the mandate on your UPI app. To complete the process, you should have an demat account. If you don't have one, open a demat account with Upstox.
How to check Quest Laboratories IPO Allotment Status?
For Quest Laboratories IPO Allotment status check you can visit this link, select the desired IPO and enter your PAN to check the allotment status.
What is Quest Laboratories IPO GMP?
You can check out here: Quest Laboratories IPO GMP